Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Immunovant (IMVT) Shares Issued (2019 - 2026)

Immunovant filings provide 7 years of Shares Issued readings, the most recent being $516.7 million for Q4 2025.

  • Quarterly Shares Issued rose 20869.2% to $516.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $545.1 million through Dec 2025, up 9948.39% year-over-year, with the annual reading at $4.8 million for FY2025, 15.51% down from the prior year.
  • Shares Issued hit $516.7 million in Q4 2025 for Immunovant, up from $24.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $516.7 million in Q4 2025 and bottomed at -$129000.0 in Q4 2021.
  • Average Shares Issued over 5 years is $32.7 million, with a median of $730000.0 recorded in 2024.
  • The largest annual shift saw Shares Issued tumbled 185.43% in 2021 before it surged 20869.2% in 2025.
  • Immunovant's Shares Issued stood at -$129000.0 in 2021, then soared by 412.4% to $403000.0 in 2022, then skyrocketed by 671.96% to $3.1 million in 2023, then fell by 20.8% to $2.5 million in 2024, then surged by 20869.2% to $516.7 million in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Shares Issued are $516.7 million (Q4 2025), $24.6 million (Q3 2025), and $2.9 million (Q2 2025).